期刊文献+

临床感染患者分离的肠球菌属耐药性及耐药基因的研究 被引量:14

Drug Resistance and Drug-resistant Genes of Enterococcus from Clinical Infective Patients
在线阅读 下载PDF
导出
摘要 目的研究分析临床感染患者分离的肠球菌属细菌耐药性及耐药基因。方法对临床分离出的72株肠球菌属进行菌株鉴定、药敏试验和氨基糖苷类〔aac(6′)/aph(2″)、aph(3′)-Ⅲ、ant(6)-Ⅰ〕、大环内酯类(ermB)、四环素类(tetM)、糖肽类耐药相关基因(vanA、vanB)和Ⅰ类整合子(IntⅠ)检测。结果72株肠球菌属对抗菌药物耐药率分别为青霉素(41.67%)、高浓度庆大霉素(86.11%)、高浓度链霉素(88.88%)、红霉素(83.33%)、四环素(52.78%)、呋喃妥因(16.67%)、左氧氟沙星(27.78%)、万古霉素(0);72株肠球菌属共检出aac(6′)/aph(2″)基因60株,aph(3′)-Ⅲ基因44株,ant(6)-Ⅰ基因56株,ermB基因52株,tetM基因38株,IntⅠ基因32株,未检出vanA和vanB基因。结论肠球菌属对临床常用的抗菌药物皆不同程度存在耐药,尚未发现耐万古霉素肠球菌,临床医生应重视肠球菌属所致感染的诊断与治疗,合理应用抗菌药物,避免耐药菌株造成的医院感染暴发流行。 OBJECTIVE To study the drug resistance and drug-resistant genes of Enterococcus from clinical infective patients. METHODS The drug resistance aac(6')/aph(2"), aph(3')-Ⅲ and ant(6)-I genes of aminoglycoside, ermB gene of macrolide, tetM gene of tetracycline, vanA and vanB genes of glycopeptides and Int I were detected in 72 Enterococcus strains. RESULTS In all 72 Enterococcus strains, 60 isolates were with positive aac(6')/aph (2"), 44 isolates were with positive aph(3')-Ⅲ , 56 isolates were with positive ant(6)-I , 52 isolates were with positive ermB, 38 isolates were with positive tetM, 32 isolates were with positive Int I , and none Enterococcus isolates were with positive vanA or vanB. CONCLUSIONS Enterococcus are the conditioned pathogens. In recent years, because of antibiotic extensive application, the Enterococcus infection is increasing continuously, having become one of the major pathogens responsible for hospital-acquired infection. Enterococcus are resistant to clinically common used 7 kinds of antibiotics in different degree excluding vancomycin. The clinical doctor should value the diagnosis and treatment of Enterococcus and adopt the different treatment projects to meet the different characteristics of Enterococcus'infection.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2008年第8期1057-1060,共4页 Chinese Journal of Nosocomiology
关键词 肠球菌属 耐药基因 耐药性 整合子 Enterococcus Drug-resistant gene Drug resistance Integron
  • 相关文献

参考文献12

  • 1颜英俊,刘华,喻华,杜琼,黄文方.肠球菌耐药趋势研究及抗感染用药建议[J].现代检验医学杂志,2005,20(1):64-66. 被引量:6
  • 2CISI/NCCLS. Performance standards for antimicrobial susceptibility testing[S]. NCCLS,2005. 52-55. 110-115.
  • 3叶信予,吕元.肠球菌耐药及临床对策[J].检验医学,2004,19(2):160-162. 被引量:11
  • 4糜祖煌,陆亚华.氨基糖苷类修饰酶及其基因检测[J].现代实用医学,2004,16(1):13-14. 被引量:143
  • 5Chow JW, Lemer SA, Zervos MJ, et al. Multiplex PCR for detection of aminoglycoside resistance genes in enterococci [J]. Antimicrob Agents Chemother, 2003,47 : 1423-1426.
  • 6Qu TT,Chen YG,Yu YS,et al. Genotypic diversity and epi demiology of high level gentamicin resistant Enterococcus in a Chinese hospital[J]. J Infect,2006,52(2):124-130.
  • 7Zarrilli R, Tripodi MF, Di Popolo A,et al. Molecular epidemi ology of high level aminoglycoside-resistant enterococci isola ted from patients in a university hospital in southern Italy [J]. J Antimicrob Chemother, 2005,56(5) :827-835.
  • 8Udo EE,Al-Sweih N,John P,et al. Characterization of high- level aminoglycoside-resistant enterococci in Kuwait hospitals[J]. Microb Drug Resist,2004,10(2) :139-145.
  • 9Woolford N. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci[J]. Microb Drug Resist,2003,24(4) : 175- 176.
  • 10Oprea SF, Zaidi N, Donabedian SM, et al. Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis [J]. J Antimicrob Chemother, 2004,53 (4) : 626-630.

二级参考文献26

  • 1马俊春 周仁.对高浓度氨基糖苷类耐药菌株肠球菌的调查[J].中华医学检验杂志,1998,21:73-75.
  • 2Facklam R R, Sahm D F. Enterococcus. Manual of Clinicai Microbiology[M]. 6 th ed. Washington D C,A S press,1995:308.
  • 3陈代杰.抗菌生物与细菌耐药性[M].上海:华东理工大学出版社,2001.90-111.
  • 4Leverstein-Van-Hall MA, Paauw A, Box AT, et al. Presence of integron-associated resistance in the community is widespread and contributes to multidrug resistance in the hospital. J Clin Microbiol, 2002, 40(8): 3038-3040.
  • 5Docquier JD, Riccio ML, Mugnaioli C, et al. IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother, 2003, 47(5): 1522-1528.
  • 6Severino P, Magalhaes VD. Integrons as tools for epidemiological studies. Clin Microbiol Infect, 2004, 10(2): 156-162.
  • 7Barlow RS, Pemberton JM, Desmarchelier PM, et al. Isolation and characterization of integron-containing bacteria without antibiotic selection. Antimicrob Agents Chemother, 2004, 48(3): 838-842.
  • 8Barbolla R, Catalano M, Orman BE, et al. Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob Agents Chemother, 2004 , 48(2): 666-669.
  • 9Gallardo F, Ruiz J, Soto SM, et al. Different antibiotic resistance mechanisms associated with integrons in clinical isolates of Salmonella typhimurium. Rev Esp Quimioter, 2003, 16(4): 398-402.
  • 10Yu HS, Lee JC, Kang HY, et al. Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea. J Antimicrob Chemother, 2004, 53(3): 445-450.

共引文献158

同被引文献91

引证文献14

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部